Klaus D. Schleim

633 total citations
21 papers, 511 citations indexed

About

Klaus D. Schleim is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Klaus D. Schleim has authored 21 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Klaus D. Schleim's work include Growth Hormone and Insulin-like Growth Factors (13 papers), Regulation of Appetite and Obesity (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Klaus D. Schleim is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (13 papers), Regulation of Appetite and Obesity (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Klaus D. Schleim collaborates with scholars based in United States and Japan. Klaus D. Schleim's co-authors include Arthur A. Patchett, Ravi P. Nargund, Lihu Yang, Thomas M. Jacks, Roy G. Smith, Gerard J. Hickey, William P. Feeney, Kang Cheng, Wanda Chan and R G Smith and has published in prestigious journals such as The Journal of Immunology, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Klaus D. Schleim

21 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus D. Schleim United States 13 241 194 156 128 97 21 511
Sylvia Ketterer Switzerland 11 251 1.0× 244 1.3× 178 1.1× 121 0.9× 249 2.6× 15 855
Maria V. Silva United States 6 465 1.9× 49 0.3× 243 1.6× 385 3.0× 95 1.0× 8 631
K. Takekawa Japan 8 50 0.2× 91 0.5× 147 0.9× 17 0.1× 149 1.5× 13 420
Lutz Pridzun Germany 10 105 0.4× 24 0.1× 70 0.4× 84 0.7× 124 1.3× 18 347
Stacey Conarello United States 6 122 0.5× 357 1.8× 132 0.8× 53 0.4× 192 2.0× 10 643
Gilbert W. Kim United States 8 73 0.3× 41 0.2× 88 0.6× 53 0.4× 147 1.5× 9 390
Julian C. Williams United States 14 42 0.2× 20 0.1× 154 1.0× 43 0.3× 135 1.4× 23 439
Motoyuki Moriga Japan 12 36 0.1× 46 0.2× 67 0.4× 56 0.4× 173 1.8× 51 494
Zhiying Jin United States 8 573 2.4× 72 0.4× 374 2.4× 427 3.3× 234 2.4× 12 862
Annick Tsocas France 12 249 1.0× 84 0.4× 138 0.9× 207 1.6× 164 1.7× 25 663

Countries citing papers authored by Klaus D. Schleim

Since Specialization
Citations

This map shows the geographic impact of Klaus D. Schleim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus D. Schleim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus D. Schleim more than expected).

Fields of papers citing papers by Klaus D. Schleim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus D. Schleim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus D. Schleim. The network helps show where Klaus D. Schleim may publish in the future.

Co-authorship network of co-authors of Klaus D. Schleim

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus D. Schleim. A scholar is included among the top collaborators of Klaus D. Schleim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus D. Schleim. Klaus D. Schleim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2007). Highly potent growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(13). 3657–3659. 8 indexed citations
2.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2003). Substituted bridged phenyl piperidines: orally active growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 13(10). 1817–1820. 5 indexed citations
3.
Koo, Gloria C., Christopher Huang, Ramon E. Camacho, et al.. (2001). Immune Enhancing Effect of a Growth Hormone Secretagogue. The Journal of Immunology. 166(6). 4195–4201. 86 indexed citations
4.
Zhou, Changyou, Liangqin Guo, Yanping Pan, et al.. (2001). Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 11(3). 415–417. 16 indexed citations
5.
Palyha, Oksana, Scott D. Feighner, Carina P. Tan, et al.. (2000). Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to Humans. Molecular Endocrinology. 14(1). 160–169. 95 indexed citations
6.
Schleim, Klaus D., Thomas M. Jacks, Patrick N. Cunningham, et al.. (1999). Increases in Circulating Insulin-Like Growth Factor I Levels by the Oral Growth Hormone Secretagogue MK-0677 in the Beagle Are Dependent upon Pituitary Mediation1. Endocrinology. 140(4). 1552–1558. 26 indexed citations
7.
Yang, Lihu, Kwan Leung, Tom Jacks, et al.. (1999). Thiazole-derived potent, highly bioavailable short duration growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 9(13). 1761–1766. 4 indexed citations
8.
Pasternak, Alexander, Yanping Pan, Philip E.J. Sanderson, et al.. (1999). Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization. Bioorganic & Medicinal Chemistry Letters. 9(3). 491–496. 17 indexed citations
9.
10.
11.
Barakat, Khaled J., Wanda Chan, Thomas M. Jacks, et al.. (1998). Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(11). 1431–1436. 15 indexed citations
12.
Yang, Lihu, Kristine Prendergast, Kang Cheng, et al.. (1998). Potent 3-spiropiperidine growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(1). 107–112. 39 indexed citations
13.
Hickey, Gerard J., Thomas M. Jacks, Klaus D. Schleim, et al.. (1997). Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. Journal of Endocrinology. 152(2). 183–192. 38 indexed citations
14.
Lieber, Richard L., Thomas M. Jacks, Klaus D. Schleim, et al.. (1997). Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization. Journal of Orthopaedic Research®. 15(4). 519–527. 21 indexed citations
15.
Tata, James R., Zhijian Lu, Thomas M. Jacks, et al.. (1997). The design and synthesis of orally active short duration spiroindane growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 7(17). 2319–2324. 9 indexed citations
16.
Jacks, Thomas M., R G Smith, Klaus D. Schleim, et al.. (1996). MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.. Endocrinology. 137(12). 5284–5289. 35 indexed citations
17.
Jacks, Thomas M., Klaus D. Schleim, Brinton M. Miller, et al.. (1983). Quaternary heterocyclylamino .BETA.-lactams. V. L-640,876 treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets.. The Journal of Antibiotics. 36(1). 70–75. 3 indexed citations
18.
McManus, Edward C., et al.. (1979). Eimeria tenella: Specific reversal of t-butylaminoethanol toxicity for parasite and host by choline and dimethylaminoethanol. Experimental Parasitology. 47(1). 13–23. 1 indexed citations
19.
Olson, G. J., et al.. (1978). Battery Efficacy Studies with Arprinocid against Field Strains of Coccidia. Poultry Science. 57(5). 1245–1250. 6 indexed citations
20.
Miller, Brinton M., et al.. (1977). Anticoccidial and Tolerance Studies in the Chicken with Two 6-Amino-9-(substituted benzyl)purines. Poultry Science. 56(6). 2039–2044. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Ketterer Breakdown of academic impact, for papers by Maria V. Silva Breakdown of academic impact, for papers by K. Takekawa Breakdown of academic impact, for papers by Lutz Pridzun Breakdown of academic impact, for papers by Stacey Conarello Breakdown of academic impact, for papers by Gilbert W. Kim Breakdown of academic impact, for papers by Julian C. Williams Breakdown of academic impact, for papers by Motoyuki Moriga Breakdown of academic impact, for papers by Zhiying Jin Breakdown of academic impact, for papers by Annick Tsocas
Rankless by CCL
2026